exploiting unexpected nad metabolic vulnerabilities in ppm1d-mutant gliomas
Published 5 years ago • 393 plays • Length 23:41Download video MP4
Download video MP3
Similar videos
-
32:30
dipg-associated ppm1d mutations drive a new form of cimp
-
0:21
diminished opening of a bileaflet mechanical aortic valve and subsequent restoration
-
0:55
molecular testing for the evaluation of colorectal cancer
-
16:59
targeted therapy-braf inhibitors and beyond
-
54:11
yale cancer center grand rounds
-
21:17
tracking down a mutant and paking up a punch structural studies into the regulation and dysregulatio
-
43:47
integrated machine-learning to navigate multi-level complexities of cancer
-
1:33
ranjit bindra, md, phd, yale cancer center/smilow cancer hospital
-
22:35
targeting apkc diables oncogenic signaling by both the egfr and the proinflammatory cytokine tnfa in
-
10:35
statistical review – early trial cessation – when, why and how to interpret with dr. david harrin...
-
0:26
false: “i am braf negative. that means i am going to be okay.”
-
4:59
nanoparticle technology to fight ovarian cancer
-
15:14
yale cancer center grand rounds
-
31:42
cancer genomics: evaluating the overall impact of passenger mutations
-
54:04
yale cancer center grand rounds: matthew kulke, md
-
1:44
yale cancer center- eating nuts may aid colon cancer survival
-
2:17
detecting “invisible” brain tumors with precision diagnostics | penn precision medicine